Smith RA, Cokkinides V, Eyre HJ.: “American Cancer Society Guidelines for the Early Detection of Cancer, 2003. Data on file, Beckman Coulter, Inc., Hemoccult ICT Product Instructions 2011Ģ. Bioz Stars score: 86/100, based on 1 PubMed citations.
Fecal immunochemical tests, like Hemoccult ICT, are part of the standard of care for colorectal cancer screening.(2) Hemoccult ICT is the most clinically proven fecal immunochemical test with high sensitivity and specificity(1). Article Title: Safety, pharmacokinetics and pharmacodynamics of multiple oral doses of apixaban, a factor Xa inhibitor, in healthy subjects Article Snippet: Subjects had faecal occult blood testing (Hemoccult sensa® Beckman Coulter Inc., Brea, CA, USA) performed at screening and on days 2 to 1, days 3 to 4, days 6 to 7, and before study discharge on day 10.Safe and non-invasive, Hemoccult ICT is very patient friendly, as there are no diet or drug restrictions for patients to follow while they are using it, which helps increase patient compliance. Because of its superior specificity for lower GI bleeding, Hemoccult ICT is an ideal screening tool for colorectal cancer (CRC), and this specificity also reduces the number of false positive test results. It is clinically proven to detect bleeding associated with more cancers and polyps than traditional guaiac-based FOBTs.
Hemoccult ICT is an immunochemical FOBT (iFOBT or FIT). Hemoccult® ICT is the latest and most advanced fecal occult blood test (FOBT) in the Hemoccult product line.